EUVIMEDEUVIMED entdecken
KommentarRandomisierte kontrollierte Studie

Comment on: Preconditioning program reduces the incidence of prolonged hospital stay after lung cancer surgery: results from the Move For Surgery randomized clinical trial

Guang-Zhao Shao, Xing-Kai Liu, Wei Zhang, Zhong-Qi Fan, Guo-Yue Lv, Tian Yang iD

British Journal of Surgery · 2024

DOI: 10.1093/bjs/znad343 ↗

Kurz gefasst

Kommentar in der Zeitschrift British Journal of Surgery, 2024. Verfasst von Guang-Zhao Shao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, General Surgery Centre, First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit nennt 1 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Editor We read with great interest the paper on the randomized controlled trial evaluating the impact of the Move For Surgery (MFS) program on postoperative outcomes in patients with early-stage non-small cell lung cancer1. Although the study provides valuable insights, we have several concerns regarding its design, methodology, and potential biases. First, the choice of postoperative hospital stay as the primary endpoint, over the more robust measure of the incidence of respiratory complications, is notably perplexing. As the authors have stated explicitly on the ClinicalTrials.gov website (NCT03689634), this study hypothesized that patients training with MFS would have lower respiratory complication rates and recover better. Given this clear objective, it is puzzling why a more direct and objective measure was not chosen as the primary endpoint. The selected metric, although seemingly straightforward, is inherently susceptible to various subjective influences, including hospital policies, individual physician decisions, and even patient preferences. Such a metric, being more malleable, can easily be influenced, casting doubts on the reliability of the results. Second, the apparent non-blinding of patients and researchers poses a substantial risk of bias. Patients, discerning their group through the presence or absence of wearable activity trackers (Fitbit®, San Francisco, CA, USA), might develop biases stemming from expectations, psychological suggestions, or placebo effects. Simultaneously, noting whether patients were equipped with Fitbit® devices, researchers could deduce group assignments, potentially influencing decisions, especially around hospital discharge, skewing results. Third, the notable discrepancy between the initially projected sample size of 186 and the final analysed participant count of 95 (45 plus 50) is alarming. Such a significant reduction in sample size can undermine the statistical power of the study, risking inconclusive or misleading conclusions. In conclusion, although the MFS trial offers intriguing findings, it is paramount to consider methodological concerns when interpreting its results. Future trials should prioritize rigorous designs to allow more generalizable and reliable conclusions to be made. G.-Z.S., X.-K.L., and W.Z. contributed equally to this work. Guang-Zhao Shao (Investigation, Methodology), Xin-Kai Liu (Investigation, Methodology, Supervision, Writing—review & editing), Wei Zhang (Investigation, Methodology, Validation, Writing—original draft), Zhongqi Fan (Investigation, Writing—review & editing), Guoyue Lv (CRediT contribution not specified), and Tian Yang (Investigation, Methodology). This letter is linked to the article by Patel et al. To view this article, visit https://doi.org/10.1093/bjs/znad252.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsHumansIncidenceLength of StayPostoperative ComplicationsRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, General Surgery Centre, First Hospital of Jilin University, Changchun, China.
  • Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Nantong, China.
  • Department of Hepatobiliary Surgery, Third Affiliated Hospital of Navy Medical University, Shanghai, China.

ORCID-Profile: Tian Yang

Zitieren

APA

Shao, G. Z., Liu, X. K., Zhang, W., Fan, Z. Q., Lv, G. Y., & Yang, T. (2024). Comment on: Preconditioning program reduces the incidence of prolonged hospital stay after lung cancer surgery: results from the Move For Surgery randomized clinical trial. British Journal of Surgery. https://doi.org/10.1093/bjs/znad343

Vancouver

Shao GZ, Liu XK, Zhang W, Fan ZQ, Lv GY, Yang T. Comment on: Preconditioning program reduces the incidence of prolonged hospital stay after lung cancer surgery: results from the Move For Surgery randomized clinical trial. British Journal of Surgery. 2024. doi:10.1093/bjs/znad343

BibTeX
@article{Shao2024,
  author = {Shao, Guang-Zhao and Liu, Xing-Kai and Zhang, Wei and Fan, Zhong-Qi and Lv, Guo-Yue and Yang, Tian},
  title = {Comment on: Preconditioning program reduces the incidence of prolonged hospital stay after lung cancer surgery: results from the Move For Surgery randomized clinical trial},
  journal = {British Journal of Surgery},
  year = {2024},
  doi = {10.1093/bjs/znad343}
}
Kostenlos starten →